Nur Afiqah Mohd Salleh1,2,3, Jenna Van Draanen2,4, Ekaterina Nosova2,5, Rolando Barrios6,7, M-J Milloy2,5, Lindsey Richardson2,4. 1. Interdisciplinary Studies Graduate Program, University of British Columbia. 2. British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada. 3. Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. 4. Department of Sociology. 5. Department of Medicine, University of British Columbia. 6. BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital. 7. Vancouver Coastal Health, Vancouver, British Columbia, Canada.
Abstract
OBJECTIVE: To examine the relationship between poverty, operationalized using a novel material security measure, and adherence to antiretroviral therapy (ART) among people who use illicit drugs (PWUD) in a context of universal access to HIV care. DESIGN: We analyzed data from a community-recruited prospective cohort in Vancouver, Canada (n = 623), from 2014 to 2017. METHODS: We used multivariable generalized mixed-effects analyses to estimate longitudinal factors associated with mean material security score. We then estimated the association between achieving at least 95% adherence to ART and overall mean material score, as well as mean score for three factors derived from a factor analysis. The three-factor structure, employed in the current analyses, were factor 1 (basic needs); factor 2 (housing-related variables) and factor 3 (economic resources). RESULTS: Recent incarceration [β-coefficient (β) = -0.176, 95% confidence interval (95% CI): -0.288 to -0.063], unmet health needs [β = -0.110, 95% CI: -0.178 to -0.042), unmet social service needs (β = -0.264, 95% CI: -0.336 to -0.193) and having access to social services (β= -0.102, 95% CI: -0.1586 to -0.0465) were among the factors associated with lower material security scores. Contrary to expectations that low levels of material security in this population would lead to poor ART adherence, we did not observe a significant relationship between adherence and overall material security score, or for each factor individually. CONCLUSION: Our findings highlight the potentially important role of no-cost, universal access to HIV prevention and treatment, in mitigating the impact of socioeconomic disadvantage on ART adherence.
OBJECTIVE: To examine the relationship between poverty, operationalized using a novel material security measure, and adherence to antiretroviral therapy (ART) among people who use illicit drugs (PWUD) in a context of universal access to HIV care. DESIGN: We analyzed data from a community-recruited prospective cohort in Vancouver, Canada (n = 623), from 2014 to 2017. METHODS: We used multivariable generalized mixed-effects analyses to estimate longitudinal factors associated with mean material security score. We then estimated the association between achieving at least 95% adherence to ART and overall mean material score, as well as mean score for three factors derived from a factor analysis. The three-factor structure, employed in the current analyses, were factor 1 (basic needs); factor 2 (housing-related variables) and factor 3 (economic resources). RESULTS: Recent incarceration [β-coefficient (β) = -0.176, 95% confidence interval (95% CI): -0.288 to -0.063], unmet health needs [β = -0.110, 95% CI: -0.178 to -0.042), unmet social service needs (β = -0.264, 95% CI: -0.336 to -0.193) and having access to social services (β= -0.102, 95% CI: -0.1586 to -0.0465) were among the factors associated with lower material security scores. Contrary to expectations that low levels of material security in this population would lead to poor ART adherence, we did not observe a significant relationship between adherence and overall material security score, or for each factor individually. CONCLUSION: Our findings highlight the potentially important role of no-cost, universal access to HIV prevention and treatment, in mitigating the impact of socioeconomic disadvantage on ART adherence.
Authors: Kate Heath; Hasina Samji; Bohdan Nosyk; Guillaume Colley; Mark Gilbert; Robert S Hogg; Julio Sg Montaner Journal: Int J Epidemiol Date: 2014-04-02 Impact factor: 7.196
Authors: M J Milloy; Thomas Kerr; Jane Buxton; Tim Rhodes; Silvia Guillemi; Robert Hogg; Julio Montaner; Evan Wood Journal: J Infect Dis Date: 2011-05-01 Impact factor: 5.226
Authors: Evan Wood; Robert S Hogg; Viviane Dias Lima; Thomas Kerr; Benita Yip; Brandon D L Marshall; Julio S G Montaner Journal: JAMA Date: 2008-08-06 Impact factor: 56.272
Authors: Evan Wood; Julio S G Montaner; Benita Yip; Mark W Tyndall; Martin T Schechter; Michael V O'Shaughnessy; Robert S Hogg Journal: Antivir Ther Date: 2004-04
Authors: Jack Stone; Hannah Fraser; Aaron G Lim; Josephine G Walker; Zoe Ward; Louis MacGregor; Adam Trickey; Sam Abbott; Steffanie A Strathdee; Daniela Abramovitz; Lisa Maher; Jenny Iversen; Julie Bruneau; Geng Zang; Richard S Garfein; Yung-Fen Yen; Tasnim Azim; Shruti H Mehta; Michael-John Milloy; Margaret E Hellard; Rachel Sacks-Davis; Paul M Dietze; Campbell Aitken; Malvina Aladashvili; Tengiz Tsertsvadze; Viktor Mravčík; Michel Alary; Elise Roy; Pavlo Smyrnov; Yana Sazonova; April M Young; Jennifer R Havens; Vivian D Hope; Monica Desai; Ellen Heinsbroek; Sharon J Hutchinson; Norah E Palmateer; Andrew McAuley; Lucy Platt; Natasha K Martin; Frederick L Altice; Matthew Hickman; Peter Vickerman Journal: Lancet Infect Dis Date: 2018-10-29 Impact factor: 71.421
Authors: Nur Afiqah Mohd Salleh; Ahsan Ahmad; Balasingam Vicknasingam; Adeeba Kamarulzaman; 'Abqariyah Yahya Journal: Int J Environ Res Public Health Date: 2022-07-24 Impact factor: 4.614
Authors: Lindsey Richardson; Anita Minh; Deb McCormack; Allison Laing; Skye Barbic; Kanna Hayashi; M-J Milloy; Kimberly R Huyser; Kathleen Leahy; Johanna Li Journal: Int J Environ Res Public Health Date: 2022-08-22 Impact factor: 4.614